{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"192.2","value":"310000"},{"comment":"NA: Geo-CV could not be calculated for 1 participant.","groupId":"OG001","spread":"NA","value":"31500"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"AUC0-28d: CR/CRi"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"116.9","value":"301000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"AUC0-28d: NR"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"177.4","value":"768000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"AUC0-28d: Unknown"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"190.9","value":"341000"},{"comment":"NA: Geo-CV could not be calculated for 1 participant.","groupId":"OG001","spread":"NA","value":"31500"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"AUC0-28d: All Participants"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"230.1","value":"462000"},{"comment":"NA: Geo-CV could not be calculated for 1 participant.","groupId":"OG001","spread":"NA","value":"74700"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"AUC 0-84d: CR/CRi"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"75.5","value":"1130000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"AUC 0-84d: NR"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"202.4","value":"984000"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"0"}],"units":"Participants"}],"title":"AUC 0-84d: Unknown"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"225.3","value":"521000"},{"comment":"NA: Geo-CV could not be calculated for 1 participant.","groupId":"OG001","spread":"NA","value":"74700"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"title":"AUC 0-84d: All Participants"}],"denoms":[{"counts":[{"groupId":"OG000","value":"75"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"AUC (area under curve) from day of infusion to day 28 or other disease assessment days, in peripheral blood (% or copies/μg x days), reported by CR/CRi, no response (NR), Unknown and by All participants. D28 refers to the timepoint for definition of responder populations, whereas 84 days is the actual timepoint for endpoint assessment. : AUC is defined based on the time window i.e., AUC from 0 to 84 days after infusion. Therefore, the time frame specifies the maximum time for up to which the data are used for estimation of AUC (84 days for AUC84d).","dispersionType":"Geometric Coefficient of Variation","groups":[{"description":"Pediatric patients with relapsed or refractory B-cell ALL who were treated with single dose of tisagenlecleucel (CTL019).","id":"OG000","title":"Main Cohort: Single Dose of CTL019"},{"description":"Pediatric B-ALL patients who are very high risk at first relapse.","id":"OG001","title":"Cohort 1: Single Dose of CTL019"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"PAS: The PAS consisted of patients in the FAS who had at least one sample providing evaluable cellular kinetic data for tisagenlecleucel.","reportingStatus":"POSTED","timeFrame":"0 to 84 days after infusion","title":"Pharmacokinetics (PK) Parameter: AUCs by qPCR in Peripheral Blood, by Day 28 Disease Response by IRC","type":"SECONDARY","unitOfMeasure":"copies/ug*days"}